SPIRIVA<sup>®</sup> Respimat<sup>®</sup> mode of action | Spiriva Respimat
SPIRIVA® Respimat® Mode of Action
SPIRIVA® Respimat® is a long-acting, anticholinergic agent. It exhibits pharmacological effects through inhibition of M3-receptors.
This short animated video shows the mode of action (MoA) of SPIRIVA® (tiotropium) Respimat® in the treatment of asthma. Binding to M3 receptors, SPIRIVA® Respimat® blocks acetylcholine, which plays a significant role in the pathophysiology of asthma, and so alleviates bronchoconstriction.